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Abstract
Background: The importance of exchanging sucrose for artificial sweeteners on risk factors for developing
diabetes and cardiovascular diseases is not yet clear.
Objective: To investigate the effects of a diet high in sucrose versus a diet high in artificial sweeteners on
fasting and postprandial metabolic profiles after 10 weeks.
Design: Healthy overweight subjects were randomised to consume drinks and foods sweetened with either
sucrose ( 2 g/kg body weight) (n  12) or artificial sweeteners (n  11) as supplements to their usual diet.
Supplements were similar on the two diets and consisted of beverages ( 80 weight%) and solid foods
(yoghurts, marmalade, ice cream, stewed fruits). The rest of the diet was free of choice and ad libitum. Before
(week 0) and after the intervention (week 10) fasting blood samples were drawn and in week 10, postprandial
blood was sampled during an 8-hour meal test (breakfast and lunch).
Results: After 10 weeks postprandial glucose, insulin, lactate, triglyceride, leptin, glucagon, and GLP-1 were
all significantly higher in the sucrose compared with the sweetener group. After adjusting for differences in
body weight changes and fasting values (week 10), postprandial glucose, lactate, insulin, GIP, and GLP-1
were significantly higher and after further adjusting for differences in energy and sucrose intake, postprandial
lactate, insulin, GIP, and GLP-1 levels were still significantly higher on the sucrose-rich diet.
Conclusion: A sucrose-rich diet consumed for 10 weeks resulted in significant elevations of postprandial
glycaemia, insulinemia, and lipidemia compared to a diet rich in artificial sweeteners in slightly overweight
healthy subjects.
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T
he effect on health of a high intake of sugars
(fructose, sucrose, high-fructose corn syrup) is still
subject to scientific and public debate. Currently, a
high intake of dietary sucrose and fructose coincides with
the worldwide pandemic of obesity, type-2 diabetes, and
cardiovascular diseases, and this has increased the con-
cerns about the possible adverse effects of excessive sugar
consumption (1, 2).
In general, it is recommended to limit the intake of
added sugars to below 10 E% primarily to ensure an
adequate intake of micronutrients (3, 4), which can be
problematic in population groups with relatively small
energy requirements (children and elderly) (5, 6). How-
ever, several other problems may arise from a large
consumption of sugars. Firstly, a relatively large con-
sumption of sugars, especially in the form of liquid sugar,
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body weight. This has been explained by subjects being
unable to compensate properly for the energy and thus
consuming excess amounts of energy when sugars are
consumed as soft drinks (79). Secondly, large cohort
studies have linked a high intake of sugar-sweetened
beverages to an increased risk of developing type-2
diabetes (1012) and both human and animal interven-
tion studies have demonstrated decreased insulin sensi-
tivity after consumption of a high-sucrose diet (1316).
Thirdly, recent studies have linked sucrose and fructose
intake to the development of lipid dysregulation, visceral
adiposity, hypertension, inflammation, and clinical cor-
onary heart disease (1618). In order to avoid excessive
intake of calories and the ensuing health hazards, it
would therefore seem prudent to exchange sucrose for a
non-calorie containing alternative such as artificial
sweeteners. Due to the scarcity of publications in this
area, the actual efficiency of this practice in the longer
term is, however, still unclear. The aim of the present
study was to investigate the effects of sucrose versus
artificial sweeteners on the fasting and postprandial
metabolic profiles after 10 weeks’ intervention in slightly
overweight subjects.
Subjects and methods
Experimental design
The study was designed as a 10 week parallel intervention
studywithtwogroupsrandomisedtoreceivesupplemental
drinks and foods containing either sucrose or artificial
sweeteners. Subjects consumed these as part of their
daily food intake and collected the supplements at the
Department of Human Nutrition every week. Subjects
were not informed about the true purpose of the study,
but were all told that they would receive supplements
containing artificial sweeteners. The study comprised a
maingroupof41subjectsandarepresentativesubgroupof
23 subjects. The present paper reports data from the
subgroup. Data on the main group have been reported
previously (8, 19). In this sub-study additional measure-
ments of fasting and postprandial metabolic profiles were
performedonatotalof23subjects(19 women and4men).
Fasting blood was sampled in week 0 and 10 and
postprandial blood sampled during an 8-hour meal test
in week 10 (day 70). Height, waist-to-hip ratio, sagittal
height, and blood pressure were measured in week 0.
Measures of body weight and composition were con-
ducted in week 0, 2, 4, 6, 8, and 10. The subjects spend
the day and night before the blood sampling days in a
respiratory chamber (data not included here). In the
morning (9 AM) body weight and waist-to-hip ratio were
measured after voiding. After 10 min of resting in a
supine position blood pressure, body composition, and
sagittal height were measured. A venflon catheter was
inserted in an antecubital arm vein and after another 10
min fasting blood samples were drawn. On the meal test
day (week 10), subjects subsequently received breakfast
(10 AM) and lunch (2 PM) at the Department. The
breakfast and lunch were precise reproductions of what
the subjects consumed the previous day, where they could
eat ad libitum from menus selected in the respiratory
chamber. The supplemental foods were eaten at breakfast
and the supplemental beverages both at breakfast and
lunch. Subjects were asked to use a maximum of 20 min
to eat the meals. After the meals, subjects were allowed to
move quietly around, read, and watch television. Post-
prandial blood samples were drawn at 30, 45, 60, 120,
180, 240 (just before lunch), 270, 285, 300, 360, 420, and
480 min after breakfast. Subjects rested in a supine
position 10 min before each blood sampling.
Subjects
The inclusion criteria were: 2050 years of age, over-
weight (BMI of 2530 kg/m
2 or  10% overweight
according to weight and height tables (20), healthy, not
dieting, and for women not pregnant or lactating. The
two study groups, the sucrose group (n12) and
the sweetener group (n11) were well matched at base-
line regarding gender, anthropometric measures, blood
pressure, and physical activity (Table 1). The study was
approved by the Municipal Ethical Committee of Co-
penhagen and Frederiksberg as being in accordance with
the Helsinki II Declaration. All subjects gave written
informed consent after the experimental procedures had
been explained to them orally and in writing.
Table 1. Characteristics of subjects at baseline (week 0)
1
Sucrose group
(n12)
Sweetener group
(n11)
Age (years) 35.392.8 35.593.6
Body weight (kg) 84.592.4 80.192.9
Height (cm) 171.892.0 170.592.2
BMI (kg/m
2) 28.790.7 27.690.8
Fat mass (kg) 31.291.1 27.591.4
Fat mass (%) 36.990.9 34.491.4
Fat-free mass (kg) 53.391.7 52.692.4
Fat-free mass (%) 63.190.9 65.691.4
Waist-to-hip ratio 0.7890.02 0.7990.03
Sagittal height (cm) 20.890.7 20.490.7
Systolic BP (mmHg) 119.594.0 116.691.9
Diastolic BP (mmHg) 72.693.6 72.092.7
Physical activity (h/wk) 8.792.5 12.192.8
Physical activity level
2 2.990.3 3.190.2
1Mean9SEM. BP: blood pressure. No significant differences between
groups (unpaired t-test).
2Self-reported, rated from 1 to 5, with 1low and 5high.
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Diets have been described in detail before (8). In brief,
subjects in the sucrose group were instructed to consume
an amount of sucrose corresponding to about 2gsucrose/kg
body weight and similar amounts of artificially sweetened
beverages and foods were given to the sweetener group.
For an 80 kg person with an energy intake of 12 MJ/d this
meant 23% of energy from sucrose. The beverages
accounted for about 80% and solid foods for about
20% by weight of the supplements. The beverages
consisted of soft drinks (Coca Cola, Fanta, and Sprite 
all from Coca Cola Tapperierne A/S, Fredericia, Den-
mark) and flavoured fruit juices (orange, raspberry,
‘sport’, and mixed). The caps were changed and all labels
were removed to hinder subjects from guessing which
drinks were ‘light’. The solid foods consisted of yoghurt
(strawberry, Peach Alexander, and cherry for the sucrose
group or strawberry-rhubarb, Peach Melba, and forest
berries for the sweetener group), jam (orange, raspberry,
and black currant), ice cream (strawberry, pistachio, and
vanilla), and canned fruits (apricots, prunes, and apples).
Except for the yoghurts the types of beverages and foods
in the two groups were matched. Because some of the
artificially sweetened products were fat-reduced, the
sweetener group was given additional butter or corn oil
to make the fat intake in the groups as similar as possible.
Besides the experimental diet, subjects were allowed to
freely consume their habitual diet throughout the inter-
vention period.
Food intake was measured by 7 day dietary records at
week 0, 5, and 10. Digital food scales with an accuracy of
1 g were used (Soehnle 8020 and 8009; Soehnle-Waagen
GmbH & Co, Murrhardt, Germany). The computer
database of foods from the National Food Agency of
Denmark (Dankost 2.0) was used to calculate the energy
and nutrient intakes (21). On the meal test day the
breakfast contained different types of bread, butter,
cheese, fruit juice, cereals, and milk. The lunch consisted
of different types of bread, butter, cheese, vegetables,
sandwich spread with meat and fish, eggs, and milk. The
supplemental foods were consumed at breakfast and the
supplemental beverages both at breakfast and lunch.
Anthropometry and blood pressure
Body weight was measured to the nearest 0.1 kg with a
digital scale (Seca model 708; Seca Mess und Wiegetech-
nik, Vogel & Halke GmbH & Co, Hamburg, Germany).
Body composition was estimated with the bioelectrical
impedance method using an Animeter (HTS-Engineering
Inc, Odense, Denmark). Fat mass (FM) and fat-free mass
(FFM) were calculated as described previously (22).
Height was measured to the nearest 0.5 cm before
intervention using a wall-monitored stadiometer. Waist
and hip circumferences were measured with a tape
measure. Sagittal height was measured in the supine
position to the nearest 0.5 cm. Blood pressure was also
measured in the supine position after 10 min of rest with
an automatically inflating cuff (UA-743, A&D Company
Ldt, Tokyo).
Laboratory analyses
Blood drawn fasting and postprandially was analysed
for concentrations of glucose, lactate, insulin, non-
esterified fatty acids (NEFA), triacylglycerol (TAG), total
cholesterol, high density lipoprotein (HDL), glucagon,
glucose-dependent insulinotropic polypeptide (GIP),
glucagon-like peptide-1 (GLP-1), and leptin. Blood was
sampled without stasis through an indwelling catheter
into iced syringes. Within 30 min, samples were centri-
fuged for 10 min at 3000g and 48C, and the supernatant
fluid was stored at 80 or 208C until analysed.
Blood for determination of plasma glucose and lactate
was collected in flouride-EDTA prepared tubes (Vacur-
ette; Greiner labortechnik; Kremsmoenster, Austria) and
was analysed by standard end-point enzymatic methods
(MPR3 Gluco-Quant Glucose/HK and MPR3 Hexoki-
nase/G&P-DH test kits; Boehringer Mannheim GmbH
Diagnostica, Copenhagen) (23, 24).
Blood for insulin analysis was sampled in dry tubes.
Determination of serum insulin was done with an
enzyme-linked immunosorbent assay using a non-com-
petitive sandwich assay (25) with a DAKO RIA insulin
kit (DAKO A/S, Glostrup, Denmark). The NEFA con-
centration in plasma was measured by enzymatic
quantitative colorimetric method (Wako NEFA test kit,
NEFA C, ACS-ACOP method; Wako Chemicals GmbH,
Germany). Concentration of serum TAG was analysed
by an enzymatic endpoint method (Test-Combination
Triacylglycerol (GPO-PAP) kit; Boehringer Mannheim
GmbH Diagnostica, Copenhagen) (26). Cholesterol and
HDL serum concentrations were measured using the
enzymatic kolorimetric Monotest Cholesterol High
Performance CHOD-PAP method (Boehringer Man-
nheim GmbH Diagnostica, Copenhagen) and the HDL-
Cholesterol precipitant method (supplementary pack to
the Monotest Cholestrol High Performance CHOD-PAP
method, Boehringer Mannheim GmbH Diagnostica,
Copenhagen).
The GIP, GLP-1, and glucagon concentrations in
plasma were all measured after extraction of plasma
with 70% ethanol (vol/vol, final concentration). For the
GIP radioimmunoassay (27) we used the C-terminally
directed antiserum R 65, which cross-reacts fully
with human GIP. Human GIP and 125-I human GIP
(70 MBq/nmol) were used for standards and tracer. The
plasma concentrations of GLP-1 were measured (28)
against standards of synthetic GLP-1 7-36amide using
antiserum code no. 89390. The glucagon radio-immu-
noassay (29) was directed against the C-terminus of the
glucagon molecule (antibody code no. 4305). Leptin was
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Gamma Counter (DRG Human Leptin RIA Kit
(RIA-1624) 1272 Clinigamma LKB Wallac Four 1½
Detectors).
Statistical analyses
All results are given as means9SEM. All statistical
analyses were performed in SAS version 8 (SAS Institute,
Cary, NC). Estimates of insulin resistance and pancreatic
b-cell function, introduced as a Homeostasis Model
Assessment (HOMA) by Matthews et al. (30) were used
as indices of insulin resistance:
HOMA-R (relative insulin resistance)glucose
(mmol=l)insulin (mU=l)=22:5:
HOMA-b (b-cell function)20insulin(mmU=ml)=
glucose (mmol=l)  3:5:
The Incremental areas under the curves (iAUC) was
calculated for all postprandial blood measures separately
for each subject as the difference between the integrated
area of the response curve and the rectangular area above
or below fasting concentrations. Differences between
groups in subject characteristics, daily energy intake
and macronutrient composition at baseline (week 0)
were analysed using Student’s unpaired t-tests.
The average daily energy and macronutrient intakes
(from food dairies, week 0, 5, and 10) and the body
weight and body composition of the sucrose and the
sweetener group were analysed using repeated measure-
ments analyses (PROC MIXED in SAS) testing the effect
of group (diet), time (week), and grouptime interac-
tion. Baseline value was used as a cofactor in analyses of
body weight and body composition.
Differences in fasting concentration of blood para-
meters, HOMA-R, HOMA-b between groups were
analysed using Student’s unpaired t-test. Changes from
week 0 to 10 between groups were analysed using
covariance test first with baseline value as a cofactor
and subsequently also with changes in body weight as a
cofactor (PROC GLM in SAS). Differences between
groups in energy and macronutrient intakes at the meal
test day (breakfast, lunch, and breakfastlunch) and
sensory evaluation of the meals were analysed using
Student’s unpaired t-tests.
Repeated measurements analyses (PROC MIXED in
SAS) over time during the meal test day were used for
analyses of postprandial blood parameters. The effects of
group, time (min) and grouptime were tested with and
without changes in body weight, fasting value (week 10),
and energy and sucrose intake on the test day (week 10)
as cofactors in the analyses. For all repeated measure-
ment analyses, the model was reduced when the group
time interaction was insignificant and Tukey-Kramers
adjusted post hoc tests were applied where appropriate.
The iAUC were analysed using analyses of variance
(ANOVA) (PROC GLM in SAS) with group as a factor.
The level of significance was PB0.05.
Results
Changes during the 10 week intervention were as follows.
Dietary intake
In week 0 the groups were well matched with regard to
energy and macronutrient intake (Table 2). During the
intervention, energy and macronutrient intake did not
change in the sweetener group. However, in the sucrose
group the intake of sucrose increased by 161% and of
carbohydrate by 31% from week 0 to 10 and in week 10,
energy intake was 32% higher compared with the sweet-
ener group (pB0.01). The amount (gram) of consumed
protein, dietary fibre, total fat or alcohol did not differ
between groups at any time, but energy density increased
significantly on the sucrose compared with the sweetener
diet (pB0.01). A similar dietary pattern was evident on
the meal test day in week 10 (Table 3).
Body weight and body composition
Analysis on body weight during the intervention showed
a significant groupweek effect (P0.03) with a body
weight increase in the sucrose group (by 1.490.6 kg in
week 10) compared with the sweetener group (1.590.6
kg in week 10). When analysing FM and lean body mass
(in kg and percentage), no significant differences were
found between groups (data not shown).
Fasting blood concentrations
Fasting concentrations of blood parameters and HOMA-
R and HOMA-b are shown in Table 4 (p-values for
changes are corrected for fasting values in week 0). In
week 0 fasting concentrations between groups were not
significantly different, except for a higher GLP-1 in the
sucrose group (PB0.001). Changes from week 0 to 10
showed an increase in fasting concentrations of insulin
(PB0.05), GIP (pB0.05), and leptin (PB0.001) in the
sucrose group compared with the sweetener group. There
was also a tendency towards a difference in HOMA-R
(p0.051) and HOMA-ß, p0.06). When change in
body weight was also used as cofactor in the analyses, all
differences between groups became non-significant. In
week 10 total fasting TAG was significantly higher in the
sucrose group (PB0.05), but the changes from week 0 to
10 were not different between groups.
Postprandial blood concentrations
For all postprandial parameters, there was a significant
effect of time (PB0.0001).
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The responses over time on the meal test day and the
iAUC for glucose, insulin, and lactate are shown in Fig. 1.
Postprandial glucose response was significantly higher,
especially after breakfast, in the sucrose group compared
with the sweetener group (group, pB0.01). Also the
iAUCs were significantly different with a slightly negative
area in the sweetener group comparedwith a positive area
in the sucrose group (pB0.05).
The insulin response was significantly higher in the
sucrose group compared with the sweetener group, again
most markedly after breakfast (grouptime effect, pB
0.05), but the difference in iAUC’s did not reach
significance (p0.06). Also for lactate a significant
grouptime effect was seen (PB0.0001), due to a larger
lactate concentration in the sucrose group compared with
the sweetener group. The iAUC was significantly higher
in the sucrose group (PB0.01).
Including fasting value and change in body weight as
cofactors in the above repeated measurements analyses
did not change the findings. The HOMA indices for
iAUC of glucose and insulin were not significantly
different, although a tendency was observed for the
HOMA-R index (48010
3 in the sucrose versus 
5010
3 in the sweetener group, p0.065).
NEFA, TAG, and leptin
The postprandial responses for NEFA, TAG, and leptin
are shown in Fig. 2. There were no significant differences
between groups in the postprandial NEFA response. For
Table 2. Average daily energy and macronutrient intakes in the sucrose and sweetener groups at baseline (week 0) and during the intervention
(week 5 and week 10)
1
P (ANOVA)
Week 0 Week 5 Week 10 Grouptime Group Time
Energy (kJ/d) Sucrose 102199886 109849855
3 117599866
4 NS 0.02 NS
Sweetener 93789597 86309708 89099337
Carbohydrate (g/d) Sucrose 294933
a 383929
b,5 386924
b,5 0.0033 B0.001 NS
Sweetener 258914 232920 24599
Carbohydrate (E%)
2 Sucrose 4892
a 6091
b,5 5691
b,5 B0.001 B0.001 B0.001
Sweetener 48924 6 924 7 92
Sucrose (g/d) Sucrose 69922
a 189914
b,5 18097
b,5 B0.001 B0.001 B0.001
Sweetener 50982 3 942 7 95
Sucrose (E%) Sucrose 1092
a 3091
b,5 2791
b,5 B0.001 B0.001 B0.001
Sweetener 9914 915 91
Dietary fibre (g/d) Sucrose 20922 1 922 0 92N S N S N S
Sweetener 19922 1 922 2 92
Fat (g/d) Sucrose 91978 0 989 0 98N S N S N S
Sweetener 86910 78997 7 96
Fat (E%) Sucrose 3591
a 2891
b 2991
ab 0.02 NS 0.01
Sweetener 34923 4 923 2 92
Protein (g/d) Sucrose 84967 4 977 9 96N S N S N S
Sweetener 78947 4 957 8 94
Protein (E%) Sucrose 1491
a 1190
b,5 1190
b,5 B0.001 0.003 0.01
Sweetener 15911 5 911 5 91
Alcohol (g/d) Sucrose 12929 921 8 95N S N S N S
Sweetener 13921 6 951 9 94
Alcohol (E%) Sucrose 4913 91
3 491N S N S N S
Sweetener 4916 916 91
Weight of food (g/d) Sucrose 30989296 37509278 37279318 NS NS 0.009
Sweetener 33749287 36149213 38409226
Energy density (kJ/g) Sucrose 3.490.2 3.090.1 3.290.2
4 NS 0.03 B0.001
Sweetener 3.090.3 2.490.2 2.490.1
1Mean9SEM. At week 0 and 10, n12 in the sucrose group and n11 in the sweetener group. At week 5 n11 in both groups. Values in the same
row with different superscript letters are significantly different (repeated measurements over weeks), PB0.05.
2E%, percentage of energy.
35Significant difference between the sucrose and sweetener groups (ANOVA):
3PB0.05,
4PB0.01,
5PB0.001.
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centration in the sucrose compared with the sweetener
group (group, pB0.05). The group difference became
insignificant after entering the change in body weight and
fasting concentrations as cofactors. Accordingly, there
was no significant difference between groups in iAUC.
Postprandial leptin response was significantly greater
in the sucrose compared with the sweetener group, both
without and with fasting concentration as a cofactor
(group, PB0.001 and pB0.05, respectively). Further
inclusion of changes in body weight as a cofactor made
the differences non-significant (p0.09). The iAUCs
were not different between groups.
Glucagon, GIP, and GLP-1
The postprandial responses for glucagon, GIP, and GLP-
1 are shown in Fig. 3. Postprandial glucagon concentra-
tions were significantly higher in the sucrose group than
in the sweetener group (group effect, pB0.05), but the
iAUCs were not different. No significant differences
between groups in any aspect of the GIP response were
found. However, when including fasting value and
changes in body weight as cofactors, there was a
significant group effect (pB0.01).
The GLP-1 concentrations were significantly greater in
the sucrose group than in the sweetener group, both
without and with fasting concentration and changes in
body weight as a cofactor (group effect, PB0.0001 and
PB0.001, respectively). The iAUCs were not significantly
different between diets.
When using fasting value, changes in body weight,
energy, and sucrose intake on the test day as cofactors in
the repeated measurements analyses, the differences in
lactate (grouptime, pB0.0001), insulin (grouptime,
pB 0.05), GIP (pB0.01), and GLP-1 (group, pB0.001)
were significant.
Discussion
The major findings in the present study were that 10
weeks intake of a diet rich in sucrose resulted in higher
postprandial concentrations of most measured blood
parameters  glucose, insulin, lactate, TAG, leptin,
glucagon, and GLP-1  in healthy, overweight subjects
compared to a diet rich in non-caloric artificial sweet-
eners. After adjusting for differences in fasting values,
changes in body weight, energy, and sucrose intake in
week 10, the differences were significant for lactate,
insulin, GIP, and GLP-1.
Table 3. Average energy and macronutrient intakes in the sucrose and sweetener groups at breakfast and lunch on the meal test day in week 10 of
the intervention
1
Breakfast Lunch Breakfastlunch
Energy (kJ) Sucrose 42649415 45319575 87969920
Sweetener 30219438 36519413 66729759
Carbohydrate (g) Sucrose 184920
2 126921 311936
2
Sweetener 113922 8497 197927
Carbohydrate (E%) Sucrose 7393
2 47936 0 92
2
Sweetener 61944 0 925 1 93
Sucrose (g) Sucrose 91913
4 49914
3 140922
4
Sweetener 10970 901 0 97
Sucrose (E%) Sucrose 3593
4 1893
4 2693
4
Sweetener 3920 902 91
Dietary fibre (g) Sucrose 7911 3 912 0 92
Sweetener 8911 5 912 2 92
Fat (g) Sucrose 21944 4 966 5 99
Sweetener 17933 9 975 6 910
Fat (E%) Sucrose 18923 7 932 8 92
Sweetener 22933 9 933 0 93
Protein (g) Sucrose 31933 8 966 9 98
Sweetener 30933 6 946 6 97
Protein (E%) Sucrose 1391
3 14911 3 91
3
Sweetener 19921 7 911 8 91
Energy density (kJ/g) Sucrose 3.590.2
3 3.690.3 3.590.2
Sweetener 2.790.2 3.690.4 3.190.2
1Mean9SEM. E%, percentage of energy. n12 in the sucrose group and n11 in the sweetener group.
24Significant difference between the sucrose and sweetener groups (Student’s unpaired t-test):
2PB0.05,
3PB0.01,
4PB0.001.
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185 g/d) was consumed in the sucrose group, mainly in
the form of liquid sugar ( 80 weight%). The ensuing
increase in total energy intake and body weight on that
diet compared with the sweetener diet has been discussed
before (8). Since changes in body weight can influence the
measured blood parameters, adjustments in the statistical
analyses were done in the present study to correct for this.
In this way the influence of the diets per se on the blood
parameters could be estimated. Still, in the real world the
values not adjusted for changes in body weight will be the
interesting ones, since these reflect the actual health
status of the person in question. The statistical correc-
tions are, therefore, mainly done in order to distinguish
between the effects of changes in body weight and the
effect of the dietary composition per se on blood
concentrations.
Sucrose consists of 50:50 glucose and fructose that
undergo different metabolic pathways after absorption
from the small intestine. The higher postprandial glucose
response on the sucrose-rich diet can be explained by the
large amount of available glucose from both sucrose and
starch on this diet. The rise in glucose can on the other
hand partly explain the large increase in postprandial
insulin levels on this diet. Part of the insulin increase may,
however, have been induced by the higher postprandial
GLP-1 responses in the sucrose group compared to the
sweetener group. It can be speculated that the constantly
high energy intake in the sucrose group throughout the
intervention has facilitated the secretion of GLP-1 by
increasing the responsiveness to macronutrients in the
small intestine (31). However, after adjusting for differ-
ences in energy and sucrose intake on the meal test
day, both insulin and GLP-1 concentrations remained
significantly higher in the sucrose group. Thus, other
factors may have played a role. The fact that GIP became
significantly higher on the sucrose diet after adjusting for
differences in fasting values, changes in body weight,
Table 4. Fasting plasma or serum concentrations of blood parameters, HOMA-R and HOMA-b in week 0 and week 10, and changes between
week 0 and week 10 of the intervention
1
Week 0 Week 10 Change
2
Glucose (mmol/l) Sucrose 4.6890.11 4.9290.12 0.2490.09
Sweetener 4.7890.08 4.8790.13 0.0990.15
Insulin (pmol/l) Sucrose 41.895.3 53.697.9 11.894.9
3
Sweetener 37.095.3 35.894.8 1.293.2
Lactate (mmol/l) Sucrose 1.0990.14 1.1190.13 0.0290.08
Sweetener 0.8390.05 0.8990.12 0.0690.10
NEFA (mmol/l) Sucrose 595944 532935 63933
Sweetener 535953 524969 10980
TAG (mmol/l) Sucrose 1.4890.18 1.7590.24
3 0.2790.12
Sweetener 1.0790.12 1.0190.14 0.0590.17
Total cholesterol (mmol/l) Sucrose 5.2090.30 5.0790.29 0.1390.19
Sweetener 5.2890.32 5.2690.36 0.0290.17
HDL-cholesterol (mmol/l) Sucrose 1.3190.06 1.3490.07 0.0390.06
Sweetener 1.4790.12 1.4790.13 0.0090.05
Glucagon (pmol/l) Sucrose 3.290.4 4.090.5 0.890.4
Sweetener 2.990.4 3.290.4 0.490.6
GIP (pmol/l) Sucrose 8.892.2 9.891.7
3 1.092.0
3
Sweetener 7.691.9 5.191.3 2.592.2
GLP-1 (pmol/l) Sucrose 13.390.9
5 13.890.7
5 0.490.5
Sweetener 8.090.6 9.490.7 1.490.8
Leptin (ng/ml) Sucrose 19.892.2 26.992.2
4 7.191.7
4
Sweetener 16.193.4 15.192.5 1.092.1
HOMA-R Sucrose 1.4690.20 1.9690.29 0.5090.18
Sweetener 1.3290.21 1.3290.2 0.0090.15
HOMA-b Sucrose 26.093.6 32.995.5 6.993.5
Sweetener 22.193.4 20.793.0 1.491.8
1Mean9SEM. N12 in the sucrose group and n11 in sweetener group. Sucrose: sucrose group, Sweetener: sweetener group, NEFA: non-esterified
fatty acids, TAG: triacylglycerol, GIP: glucose-dependent insulinotropic polypeptide, GLP-1: glucagon-like peptide-1.
2Change is calculated as week 10 minus week 0. An ANOVA was performed with week 0 value as covariate.
35Significant difference between sucrose and sweetener groups (ANOVA).
3PB0.05,
4PB0.01,
5PB0.001.
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factors played a role in the release of GIP on that diet
compared with the sweetener diet.
From the fasting results in our study, there was a
tendency that the sucrose-rich diet lead to reduced insulin
sensitivity after 10 week. This tendency disappeared,
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Fig. 1. Mean (9 SEM) plasma glucose, serum insulin, and plasma lactate concentrations and incremental areas under the
curves (iAUC) for a meal test day (week 10) in two groups who received supplementation containing either sucrose ("), n12
or artiﬁcial sweeteners (I), n11 for 10 weeks in addition to their habitual diet. Postprandial responses were tested by repeated
measurement analysis. For all curves, the time effect was signiﬁcant (PB0.0001). For glucose there was a signiﬁcant group
difference (pB0.01), and a difference in iAUC (pB0.05). For postprandial insulin there was a grouptime effect (pB0.05),
whereas the iAUC did not differ (group, p0.06). For lactate there was a signiﬁcant grouptime effect (PB0.0001) and a
difference in iAUC (PB0.01).
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some previous studies, no differences in insulin sensitivity
were found when subjects were exposed to sucrose or
starch for up to 24 days (15, 3234). In contrast, a recent
study of 10 weeks duration showed a decrease in insulin
sensitivity after consumption of fructose-sweetened com-
pared with glucose-sweetened beverages corresponding to
25 E% (16). In our study, large significant postprandial
differences in glucose and insulin concentrations were
observed, and fasting and iAUC HOMA-R index tended
to be different too. These data together with the data in
the study by Stanhope et al. (16) suggest that consump-
tion of a sucrose- or fructose-rich diet for an extended
period of time (e.g. 10 weeks) produces a less beneficial
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Fig. 2. Mean (9 SEM) plasma non-esteriﬁed fatty acids (NEFA), serum triacylglycerol (TAG), and plasma leptin
concentrations and incremental areas under the curves (iAUC) for a meal test day (week 10) in two groups who received
supplementation containing either sucrose ("), n12 or artiﬁcial sweeteners (I), n11 for 10 weeks in addition to their
habitual diet. Postprandial responses were tested by repeated measurement analysis. For all curves, the time effect was signiﬁcant
(PB0.001). For NEFA no signiﬁcant differences were seen. For postprandial TAG and leptin, there were signiﬁcant group
differences (pB0.05 and pB0.001, respectively), but the iAUCs were not different.
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(page number not for citation purpose)glycaemic and insulinemic response and a risk of devel-
oping insulin resistance compared with a diet sweetened
with non-caloric sweeteners or glucose. However, it is
likely that changes in body weight can explain part of
these findings.
We observed a large increase in lactate concentra-
tions on the sucrose diet compared with the sweetener
diet. This can probably be explained by the metabolic
fate of the fructose moiety from the sucrose molecule.
Thus, fructose present in the portal blood is efficiently
extracted by the liver and metabolised to fructose-1-
phosphate under the action of the enzyme fructokinase,
which is highly specific for fructose (35). Fructose-1-
phosphate is further metabolised to triose-phosphate
that subsequently can be converted into lactate
and released into the systemic circulation (35). In
accordance with this, postprandial lactate was shown
to be elevated both after short- and longer-term
consumption of a sucrose-rich compared with a
starch-rich diet (32, 33).
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Fig. 3. Mean (9 SEM) plasma glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1
(GLP-1) concentrations and incremental areas under the curves (iAUC) for a meal test day (week 10) in two groups who
received supplementation containing either sucrose ("), n12 or artiﬁcial sweeteners (I), n11 for 10 weeks in addition to
their habitual diet. Postprandial responses were tested by repeated measurement analysis. For all curves, the time effect was
signiﬁcant (PB0.0001). No differences were seen for GIP. For postprandial glucagon and GLP-1, there were signiﬁcant group
differences (pB0.05 and PB.0001, respectively), but no differences in iAUC.
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decade on the effects of fructose or high-fructose corn
syrup on measures of lipidemia. In vitro data indicate
that lactate is a main lipogenic precursor after fructose
administration and that the activation of pyruvate
dehydrogenase is a major regulatory step in this process.
At the same time, fructose inhibits hepatic lipid oxida-
tion, thus favouring fatty acid re-esterification and very
low density lipoprotein (VLDL)-triglycerid synthesis (35).
Due to the fructose moiety, sucrose may therefore affect
concentrations of TAG by increasing hepatic TAG
synthesis and VLDL production (36, 37).
Although total fasting TAG was higher in our study
after 10 weeks on the sucrose diet, the changes from week
0 to 10 were not significantly different between groups
(p.07). Furthermore, changes in fasting cholesterol
concentrations did also not differ between diets. Simi-
larly, fasting TAG and cholesterol concentrations did not
differ after 6 months on a low-fat, high-sucrose diet
compared with a low-fat, high-starch ad libitum diets
in the CARMEN study, in which 398 obese men and
women participated (38). It is important to note, how-
ever, that in contrast to the present study, subjects in the
CARMEN study consumed less energy and lost body
weight on the sucrose-rich diet compared with a more fat-
rich control diet  probably due to the sucrose-rich diet
consisting mostly of solid foods and not of drinks as in
the present study.
In the present study, postprandial TAG responses were
significantly higher on the sucrose diet compared with the
sweetener diet. These results are in accordance with
previous studies, where diurnal TAG levels were found
to be higher after sucrose, measured after 124 days
intake, compared with either starch or glucose (3234).
Furthermore, a recent study showed that consuming
fructose-sweetened beverages for 10 weeks increased 23-
hour postprandial triglyceride AUC and hepatic de novo
lipogenesis as well as visceral adiposity compared with
glucose-sweetened beverages (16). Since sustained eleva-
tion of plasma TAG has been proposed to be an
independent risk factor for cardiovascular diseases (39,
40) and since the diurnal TAG response was consistently
higher on the sucrose diet in the present study, it can be
speculated that this diet would lead to an increased riskof
these diseases in the long-term compared with a diet
sweetened with non-caloric sweeteners.
Not many studies have compared sucrose with artificial
sweeteners after longer-term consumption. One earlier
cross-over study looked at the effect of an intake of 45 g
sucrose (9 E%) compared with an equivalent sweetening
amount of aspartame for 6 weeks in 9 subjects with
NIDDM (41). Here no effect of the added sucrose was
observed with regard to fasting triglycerides, total or
HDL-cholesterol, glucose and HbA1c, 2-hour postpran-
dial glycaemia, and insulinemia or insulin sensitivity as
measured by the euglycemic clamp. The lack of differ-
ences in that study could, however, be due to the fairly
small sucrose challenge compared with both our study
(27 E%) and the recent study by Stanhope et al. (16),
where fructose amounted to 25 E%.
We found both increased fasting and postprandial
leptin concentrations in the sucrose compared with the
sweetener group after 10 weeks’ intervention. The differ-
ences in fasting values disappeared, however, after
adjusting for changes in body weight. This would
correspond to the fact that a higher leptin concentration
is an indicator of higher fat deposits. Overall, however,
diurnal leptin concentrations were about twice as high on
the sucrose-rich diet compared with the sweetener diet.
This could be due to the prolonged increase in insulin
concentration, since hyperinsulinemia has been found to
stimulate leptin release (42). We have previously observed
increased postprandial leptin levels after only 14 days’ ad
libitum sucrose-rich versus starch-rich diet in normal
weight subjects. This finding was also explained by
greater postprandial insulin peaks on the sucrose-rich
diet (43).
In conclusion, a sucrose-rich diet consumed for 10
weeks resulted in significant elevations of postprandial
glycaemia, insulinemia, and lipidemia compared to a diet
rich in artificial sweeteners in slightly overweight healthy
subjects. However, more studies and of longer duration
are needed to substantiate these findings.
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